Samar Almehdi: First-line chemotherapy in Iraqi patients with extensive-stage SCLC

Samar Almehdi, Medical Oncology Specialist at Iraqi Cancer Council, shared a post on LinkedIn about a recent paper she co-authored with Azher Al Zubaidi published in the Iraqi Postgraduate Medical Journal:

“Thrilled to announce that my and professor Dr. Azher Sebieh’s latest paper, titled ‘Patients Profile, Pattern of Presentation, and Response Rate to First-Line Chemotherapy in Iraqi Patients with Extensive-Stage Small Cell Lung Cancer,’ has been published in the Iraqi Postgraduate Journal!

Grateful to my co-author, mentors, and collaborators for their invaluable support throughout this journey.

I hope this research adds value to the field and sparks further discussions. Looking forward to engaging with peers on this topic!”

“Patients profile, pattern of presentation and response rate to first line chemotherapy in Iraqi patients with extensive stage small cell lung cancer”

Authors: Samar Almehdi and Azher Al Zubaidi.